semaglutide and hormone replacement therapy NW Integrative Medicine: Treatment For Weight Loss & Diabetes, Weight Management, Obesity, Overweight, in Kennewick WA, Tri-Cities WA Since 1985 semaglutide and hormone replacement therapy

It is not a GLP-1 receptor agonist drug

About 1.6 million adults in England, Scotland and Wales are estimated to have used GLP-1s for weight loss between early 2024 and early 2025, according to recently published research by University College London

Current evidence suggests that dapagliflozin may elevate the risk of bladder and breast cancers, whereas other SGLT2 inhibitors have not demonstrated such associations [10]

If you find following a regimented diet plan to be easier than making free-form dietary changes, feel free to use them, but they aren't strictly necessary

The decision to initiate pharmacotherapy requires shared decision-making, discussing realistic expectations, potential adverse effects, cost considerations, and the likely need for indefinite treatment duration